highlight
revers
genet
system
establish
recombin
replic
effici
origin
clinic
isol
stabl
mneongreen
report
develop
mneongreen
use
screen
antivir
inhibitor
ongo
pandem
caus
sever
acut
respiratori
syndrom
coronaviru
underscor
urgenc
develop
experiment
system
studi
viru
identifi
countermeasur
report
revers
genet
system
seven
complimentari
dna
cdna
fragment
span
genom
assembl
fullgenom
cdna
rna
transcrib
fullgenom
cdna
highli
infecti
electropor
cell
produc
plaqueform
unit
pfu
ml
viru
compar
clinic
isol
infectiousclonederiv
exhibit
similar
plaqu
morpholog
viral
rna
profil
replic
kinet
addit
retain
engin
molecular
marker
acquir
mutat
gener
stabl
mneongreen
introduc
report
gene
viral
genom
success
use
evalu
antivir
activ
interferon
ifn
collect
revers
genet
system
report
viru
provid
key
reagent
studi
develop
countermeasur
ys
file
provision
patent
revers
genet
system
author
conflict
interest
declar
sever
acut
respiratori
syndrom
coronaviru
caus
devast
global
pandem
xie
et
al
gener
infecti
cdna
clone
mneongreen
report
viru
recombin
report
viru
replic
effici
origin
clinic
isol
sever
acut
respiratori
syndrom
coronaviru
emerg
earli
human
case
wuhan
china
zhou
et
al
zhu
et
al
rapidli
rampag
worldwid
caus
pandem
coronaviru
diseas
rang
fever
breath
difficulti
acut
respiratori
distress
death
zhu
et
al
peopl
infect
less
month
caus
sever
diseas
older
patient
peopl
comorbid
includ
heart
diseas
diabet
health
condit
wu
mcgoogan
six
aand
bcoronavirus
known
caus
respiratori
diseas
differ
sever
includ
four
common
cold
coronavirus
two
highli
pathogen
coronavirus
sever
acut
respiratori
syndrom
sarscov
middl
east
respiratori
syndrom
merscov
emerg
sinc
respect
assiri
et
al
huang
et
al
importantli
massiv
hospit
rate
high
mortal
remain
major
threat
humankind
intervent
strategi
rapidli
pursu
key
tool
respond
emerg
virus
gener
revers
genet
system
explor
character
new
pathogen
classic
revers
genet
system
coronavirus
complic
larg
genom
size
nucleotid
exist
bacteriotox
element
genom
make
difficult
propag
n
et
al
sever
approach
devis
overcom
barrier
multipl
plasmid
system
disrupt
toxic
element
reduc
delet
mutat
use
approach
research
develop
infecti
clone
sever
coronavirus
includ
sarscov
merscov
other
menacheri
et
al
menacheri
et
al
scobey
et
al
yount
et
al
thao
et
al
recent
report
yeastbas
synthet
genom
platform
rapid
construct
infecti
clone
murin
hepat
coronaviru
mhvcov
merscov
howev
yeastplatformproduc
fulli
character
biolog
properti
eg
replic
kinet
comparison
origin
clinic
isol
character
essenti
ensur
qualiti
genet
system
rescu
recombin
virus
recapitul
biolog
featur
correspond
clinic
isol
valid
revers
genet
system
allow
rapid
character
novel
virus
develop
report
virus
gener
liveattenu
vaccin
candid
respond
emerg
infect
togeth
anim
pathogenesi
model
revers
genet
system
offer
power
tool
need
character
understand
respond
emerg
viru
outbreak
respons
ongo
pandem
develop
robust
revers
genet
system
mneongreen
report
viru
recombin
viru
deriv
system
recapitul
replic
kinet
origin
clinic
isol
addit
mneongreen
report
remain
stabl
least
five
passag
allow
use
longterm
studi
use
type
interferon
ifn
demonstr
mneongreen
viru
could
reliabl
use
studi
viral
replic
pathogenesi
well
develop
vaccin
antivir
drug
design
vitro
ligat
approach
similar
use
construct
infecti
clone
sarscov
merscov
scobey
et
al
yount
et
al
direct
assembl
fulllength
complimentari
dna
cdna
genom
figur
revers
genet
system
base
viru
strain
isol
first
report
case
us
harcourt
et
al
holshu
et
al
viral
rna
extract
passag
viru
vero
cell
use
templat
rtpcr
produc
cdna
fragment
seven
contigu
cdna
fragment
construct
cover
entir
viral
genom
figur
seven
cdna
fragment
prepar
rtpcr
wherea
other
gener
chemic
synthesi
see
method
detail
cdna
fragment
individu
clone
plasmid
vector
facilit
direct
assembl
genomelength
cdna
cdna
fragment
flank
class
ii
restrict
endonucleas
site
bsai
class
ii
endonucleas
recogn
asymmetr
dna
sequenc
cleav
outsid
recognit
sequenc
gener
uniqu
cohes
overhang
figur
digest
bsai
seven
fragment
direct
ligat
assembl
genomelength
cdna
uniqu
cohes
end
fragment
ensur
one
direct
seamless
assembl
seven
fragment
concomit
loss
restrict
enzym
site
figur
depict
detail
seven
fragment
promot
sequenc
plu
nucleotid
nucleotid
nucleotid
nucleotid
nucleotid
nucleotid
nucleotid
plu
poli
sequenc
engin
promot
poli
tail
upstream
end
downstream
end
respect
vitro
transcript
ligat
dna
expect
produc
cap
cap
analog
includ
vitro
transcript
reaction
polyadenyl
genomelength
rna
differenti
infecti
clonederiv
viru
parent
clinic
isol
engin
three
synonym
nucleotid
mutat
marker
assembl
fulllength
cdna
clone
seven
cdna
fragment
plasmid
sequenc
ensur
undesir
mutat
assembl
fulllength
cdna
seven
cdna
plasmid
digest
bsai
result
cdna
fragment
gelpurifi
figur
vitro
ligat
assembl
genomelength
cdna
three
step
ligat
produc
cdna
ligat
produc
cdna
ligat
produc
fulllength
cdna
agaros
gel
analysi
ligat
reaction
show
major
dna
product
repres
size
genomelength
cdna
kb
indic
arrow
figur
addit
sever
smaller
intermedi
cdna
product
indic
circl
vitro
transcript
use
cdna
templat
directli
ligat
without
gel
purif
gener
multipl
rna
band
among
faint
high
molecular
band
might
repres
genomelength
rna
indic
arrow
figur
togeth
sever
smaller
rna
transcript
indic
circl
recov
recombin
infecti
cdna
clone
electropor
invitrotranscrib
genomelength
rna
vero
cell
directli
electropor
rna
transcript
mixtur
figur
cell
without
purif
given
n
protein
report
enhanc
infect
coronaviru
rna
transcript
curti
et
al
yount
et
al
yount
et
al
coelectropor
mrna
encod
n
protein
fulllength
rna
transfect
cell
develop
cytopath
effect
cpe
day
transfect
produc
infecti
viru
denot
passag
viru
titer
plaqueform
unit
pfu
ml
figur
worth
emphas
high
titer
recombin
viru
produc
directli
electropor
cell
without
addit
round
cell
cultur
passag
indic
robust
system
also
suggest
lack
error
next
compar
replic
properti
recombin
viru
origin
clinic
isol
wildtyp
develop
plaqu
similar
origin
clinic
isol
figur
exhibit
equival
replic
kinet
vero
cell
figur
extend
time
point
replic
beyond
h
cpe
observ
h
infect
northern
blot
analysi
show
viral
messeng
rna
mrna
speci
clinicalisolateinfect
cell
cell
ident
predict
set
genomelength
rna
eight
subgenom
rna
figur
fullgenom
sequenc
show
recombin
viru
retain
three
engin
synonym
mutat
sequenc
chang
demonstr
rescu
viru
result
contamin
parent
viru
isol
figur
furthermor
dna
sequenc
chromatogram
show
partial
revers
three
engin
molecular
marker
figur
collect
result
demonstr
invitrotranscrib
fulllength
rna
highli
infecti
upon
electropor
cell
recombin
viru
recapitul
replic
properti
origin
clinic
isol
vero
cell
report
virus
use
tool
studi
viral
replic
pathogenesi
develop
countermeasur
establish
report
infecti
clone
engin
mneongreen
mng
gene
viral
genom
figur
similar
sarscov
report
sim
et
al
vitro
ligat
transcript
protocol
describ
use
prepar
mng
fulllength
rna
electropor
recov
pfuml
examin
whether
report
gene
attenu
viral
replic
compar
replic
properti
wt
report
virus
vero
cell
produc
plaqu
similar
icsarscovwt
compar
figur
indistinguish
replic
kinet
observ
icsarscovwt
figur
infect
develop
increas
number
mngposit
cell
time
figur
concurr
fluoresc
signal
increas
h
infect
figur
h
infect
level
fluoresc
signal
correl
initi
multipl
infect
moi
wherea
revers
trend
observ
h
infect
like
due
earlier
cpe
caus
higher
moi
fullgenom
sequenc
show
retain
three
engin
marker
addit
mutat
figur
result
indic
initi
stabl
maintain
wt
replic
express
robust
mng
vero
cell
examin
longerterm
stabil
serial
passag
report
viru
vero
cell
round
day
per
round
cell
infect
equal
pfu
passag
passag
virus
produc
compar
number
mngposit
cell
figur
next
rtpcr
perform
verifi
retent
mng
viral
genom
use
two
primer
target
insert
junction
correspond
nucleotid
viral
genom
expect
rtpcr
product
deriv
mng
virus
larger
wt
figur
lane
digest
rtpcr
product
bsrgi
locat
upstream
mng
insert
site
stui
mng
gene
develop
distinct
cleavag
pattern
report
wt
virus
wherea
virus
produc
ident
digest
pattern
figur
lane
final
sequenc
rtpcr
product
confirm
retent
mng
gene
data
shown
altogeth
result
demonstr
stabil
five
round
passag
vero
cell
given
vero
cell
defect
type
ifn
product
remain
test
whether
report
viru
stabl
passag
interferoncompet
cell
line
explor
util
use
report
viru
rapidli
screen
antivir
activ
known
inhibitor
coronavirus
previous
show
pretreat
vero
cell
type
ifn
inhibit
replic
lokugamag
et
al
explor
doserespons
effect
ifna
pretreat
icsarscovmng
replic
figur
mng
express
visual
observ
infect
cell
pretreat
highest
dose
ifna
uml
wherea
dosedepend
reduct
mng
signal
detect
intermedi
dose
uml
figur
quantif
fluoresc
readout
estim
concentr
inhibit
viral
replic
ec
uml
confirm
inhibit
ifna
figur
result
consist
previou
find
sensit
type
ifn
inhibit
report
viru
assay
requir
fewer
day
less
labor
convent
plaquereduct
assay
collect
result
indic
could
reliabl
use
studi
replic
screen
antivir
inhibitor
report
develop
fulllength
infecti
clone
report
viru
one
key
util
revers
genet
system
facilit
antivir
test
therapeut
develop
report
viru
allow
use
fluoresc
surrog
readout
viral
replic
compar
standard
plaqu
assay
median
tissu
cultur
infecti
dose
tcid
quantif
fluoresc
readout
shorten
assay
turnaround
time
sever
day
addit
fluoresc
readout
offer
quantit
measur
less
laborintens
tradit
mean
viral
titer
reduct
furthermor
mngvirusbas
assay
could
autom
highthroughput
format
screen
compound
viral
replic
proofofconcept
demonstr
treatment
type
ifn
report
viru
reliabl
reveal
efficaci
rapid
effici
manner
addit
stabil
mng
report
viru
allow
use
longerterm
studi
vivo
without
fear
lose
fluoresc
marker
thu
report
viru
offer
huge
advantag
research
commun
pharmaceut
compani
develop
therapeut
revers
genet
system
repres
major
reagent
pursuit
understand
compar
clinic
isol
recombin
wt
deficit
term
viral
rna
speci
produc
plaqu
morpholog
replic
kinet
therefor
might
use
equival
clinic
strain
mutant
virus
gener
character
mutat
effect
viral
infect
approach
allow
research
identifi
key
viral
antagonist
innat
immun
sarscov
merscov
menacheri
et
al
totura
baric
sever
mutant
virus
subsequ
employ
liveattenu
vaccin
candid
sarscov
merscov
de
wit
et
al
schindewolf
menacheri
use
system
knowledg
might
appli
current
character
mutat
might
provid
insight
pathogenesi
revers
genet
system
also
allow
explor
research
question
fundament
understand
pandem
addit
genom
sequenc
becom
avail
evolutionari
mutat
interrog
effect
viral
transmiss
diseas
outcom
exampl
delet
cover
almost
entir
observ
eight
hospit
patient
singapor
viru
isol
delet
strain
report
studi
su
et
al
fouraminoacid
insert
confer
possibl
furin
cleavag
site
report
spike
protein
absent
protein
sarscov
cov
coutard
et
al
use
infecti
clone
evalu
effect
genet
chang
remov
report
sequenc
examin
effect
viru
replic
protein
process
addit
mous
model
limit
absenc
virus
capabl
bind
mous
angiotensinconvert
enzym
point
mutat
receptor
bind
domain
protein
might
facilit
mous
adapt
develop
model
recapitul
human
diseas
standard
mous
strain
altogeth
question
exampl
infecti
clone
use
advanc
research
summari
develop
robust
revers
genet
system
use
studi
viral
replic
pathogenesi
also
establish
mng
report
reliabl
surrog
highthroughput
drug
discoveri
revers
genet
system
repres
major
tool
research
commun
significantli
advanc
opportun
countermeasur
develop
detail
method
provid
onlin
version
paper
includ
follow
inform
request
resourc
reagent
direct
fulfil
lead
contact
peiyong
shi
peshi
utmbedu
plasmid
viru
gener
studi
made
avail
request
might
requir
payment
andor
complet
materi
transfer
agreement
potenti
commerci
applic
stock
strain
deriv
first
patient
diagnos
us
viru
isol
origin
provid
dr
natali
thornburg
center
diseas
control
prevent
atlanta
ga
describ
reagent
previous
holshu
et
al
amplifi
vero
cell
world
refer
center
emerg
virus
arbovirus
wrceva
univers
texa
medic
branch
galveston
utmb
passag
use
studi
african
green
monkey
kidney
epitheli
cell
vero
purchas
american
type
cultur
collect
atcc
bethesda
md
maintain
highglucos
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
hyclon
laboratori
south
logan
ut
penicillinstreptomycin
ps
cell
grown
c
co
cultur
media
antibiot
purchas
thermofish
scientif
waltham
cell
line
test
neg
mycoplasma
clone
cdna
two
approach
taken
rapidli
obtain
stabl
cdna
first
cdna
fragment
success
synthes
genscript
compani
piscataway
nj
clone
highcopi
plasmid
contain
promot
sequenc
upstream
end
sequenc
cdna
fragment
also
synthes
found
unstabl
clone
plasmid
overcom
hurdl
cdna
fragment
obtain
revers
transcript
pcr
rtpcr
rt
perform
use
superscript
iv
firststrand
synthesi
system
thermofish
scientif
random
hexam
primer
extracellular
viral
rna
extract
supernat
vero
cell
cdna
use
templat
amplifi
fragment
high
fidel
pcr
platinum
superfi
ii
dna
polymeras
thermofish
scientif
accord
manufactur
instruct
poli
sequenc
introduc
pcr
end
untransl
region
viral
genom
amplicon
clone
singlecopi
vector
epicent
increas
stabil
cdna
plasmid
propag
e
coli
ensur
seamless
assembl
fulllength
cdna
introduc
two
cleavag
site
class
ii
restrict
enzym
bsai
end
sibl
cdna
pcr
gene
synthesi
differenti
infecti
clonederiv
viru
parent
clinic
isol
engin
three
silent
mutat
nucleotid
posit
atot
chang
ttoa
chang
ttoc
chang
construct
gene
mneongreen
sequenceoptim
synthes
insert
downstream
regulatori
sequenc
replac
entir
accord
studi
describ
previous
sim
et
al
subclon
final
valid
sanger
sequenc
assembl
fulllength
cdna
assembl
fulllength
cdna
digest
individu
cdna
plasmid
purifi
cdna
fragment
specif
cdna
fragment
obtain
digest
correspond
plasmid
enzym
bsai
fragment
obtain
digest
plasmid
enzym
pvui
cdna
fragment
obtain
digest
correspond
plasmid
snabi
pvui
snabi
includ
digest
elimin
undesir
dna
band
comigr
target
fragment
agaros
gel
fragment
restrict
enzym
digest
separ
agaros
gel
visual
darkread
lightbox
clare
chemic
research
dolor
co
excis
purifi
use
qiaquick
gel
extract
kit
qiagen
germantown
md
assembl
fulllength
cdna
ligat
seven
cdna
fragment
threestep
manner
first
equimolar
amount
mg
mg
mg
mg
ligat
pcr
tube
use
dna
ligas
mlreaction
c
h
result
dna
second
equimolar
amount
fragment
mg
mg
mg
ligat
separ
pcr
tube
produc
dna
use
ligat
condit
third
without
dna
purif
two
reaction
contain
combin
total
ml
top
addit
ligas
ml
buffer
ml
nucleasefre
water
ml
ml
reaction
final
reaction
incub
c
h
produc
fulllength
dna
afterward
fulllength
cdna
phenolchloroform
extract
isopropanol
precipit
resuspend
ml
nucleasefre
water
rna
transcript
vitro
synthes
mmessag
mmachin
transcript
kit
thermofish
scientif
accord
manufactur
instruct
modif
ml
reaction
set
ad
mg
dna
templat
ml
gtp
cap
analogtogtp
ratio
reaction
incub
c
h
remov
templat
dna
nucleas
per
manufactur
protocol
rna
phenolchloroform
extract
isopropanol
precipit
n
gene
transcript
vitro
transcrib
dna
templat
use
mmessag
mmachin
transcript
kit
ratio
cap
analog
gtp
n
gene
dna
templat
prepar
pcr
use
primer
tactgtaatacgactcactataggatgtctgataatggaccccaaaatc
uppercas
sequenc
repres
promot
underlin
sequenc
repres
end
n
gene
primer
polytnr
aggcctgagttgagtcagcac
rna
transcript
electropor
vero
cell
use
protocol
previous
describ
et
al
modif
twenti
microgram
total
rna
transcript
contain
fulllength
rna
short
rna
mg
n
gene
transcript
mix
ad
cuvett
contain
ml
vero
cell
electropor
solut
miru
singl
electr
puls
given
genepuls
apparatu
biorad
set
mf
min
recoveri
room
temperatur
electropor
cell
seed
flask
incub
c
co
next
day
cultur
fluid
replac
fb
dmem
medium
cell
monitor
daili
virusmedi
cytopath
effect
cpe
one
